Your prediction
Novozymes A/S B Stock
A loss of -2.130% shows a downward development for Novozymes A/S B.
For the coming years our community has positive and negative things to say abot the Novozymes A/S B stock. Criterium "Return on equity" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | -2.130% | 1.993% | -3.018% | -2.881% | 0.950% | 24.617% | -18.007% |
| Ems-Chemie N | 0.800% | 4.481% | 16.964% | 32.140% | 49.662% | 55.439% | 57.092% |
| Givaudan S.A. | 0.600% | 1.214% | -8.183% | -3.447% | 3.274% | 41.169% | 41.569% |
| Solvay S.A. A | - | 0.756% | 1.062% | -3.827% | -2.489% | -74.186% | -76.477% |
